Day One Biopharmaceuticals Inc (DAWN) stock forecast · rev $131.2M
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
This DAWN forecast page states what the cached financials imply — not a price target and not a guarantee. Day One Biopharmaceuticals Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Period-over-period revenue change is not in cache for DAWN, so this page does not invent a growth rate.
DAWN currently screens at market cap $656.8M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next DAWN 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the DAWN stock page.
Not investment advice.